Compare · LFMD vs OPCH
LFMD vs OPCH
Side-by-side comparison of LifeMD Inc. (LFMD) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFMD and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.54B, about 22.6x LFMD ($156.7M).
- Over the past year, LFMD is down 50.0% and OPCH is down 15.3% - OPCH leads by 34.7 points.
- LFMD has hit the wire 8 times in the past 4 weeks while OPCH has been quiet.
- OPCH has more recent analyst coverage (17 ratings vs 11 for LFMD).
- Company
- LifeMD Inc.
- Option Care Health Inc.
- Price
- $3.26+3.66%
- $23.64-0.11%
- Market cap
- $156.7M
- $3.54B
- 1M return
- -15.76%
- +8.46%
- 1Y return
- -49.96%
- -15.30%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 8
- 0
- Recent ratings
- 11
- 17
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest LFMD
- Director Larovere Joan was granted 35,000 shares, increasing direct ownership by 33% to 142,050 units (SEC Form 4)
- Director Strawn John R Jr was granted 85,000 shares, increasing direct ownership by 21% to 498,001 units (SEC Form 4)
- Director Ditrolio Joseph was granted 35,000 shares, increasing direct ownership by 13% to 308,413 units (SEC Form 4)
- Amendment: Director Simon Roberto was granted 80,810 shares, increasing direct ownership by 81% to 180,810 units (SEC Form 4)
- Director Simon Roberto was granted 85,000 shares, increasing direct ownership by 42% to 288,175 units (SEC Form 4)
- Director Macrae Calum Archibald was granted 35,000 shares, increasing direct ownership by 90% to 73,865 units (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- LifeMD to Report Second Quarter 2026 Financial Results on August 5
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Latest OPCH
- Option Care Health downgraded by Deutsche Bank with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Option Care Health downgraded by Stephens with a new price target
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations